Rutin-enabled improved systemic exposure of doxorubicin via nanostructured lipid carriers: a proof of concept through novel LC-MS/MS analysis

Neha Agarwal, Avijit Kumar Bakshi, Dilip Panwar, Patil Rohit Santosh, Prabhat Ranjan Mishra

Open source

DOI
10.1080/03639045.2026.2703044
Published
2026-07-18
Container
Drug Development and Industrial Pharmacy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/03639045.2026.2703044,
  title = {Rutin-enabled improved systemic exposure of doxorubicin via nanostructured lipid carriers: a proof of concept through novel LC-MS/MS analysis},
  author = {Neha Agarwal and Avijit Kumar Bakshi and Dilip Panwar and Patil Rohit Santosh and Prabhat Ranjan Mishra},
  year = {2026},
  journal = {Drug Development and Industrial Pharmacy},
  doi = {10.1080/03639045.2026.2703044},
  url = {https://doi.org/10.1080/03639045.2026.2703044}
}

RIS

TY  - JOUR
TI  - Rutin-enabled improved systemic exposure of doxorubicin via nanostructured lipid carriers: a proof of concept through novel LC-MS/MS analysis
AU  - Neha Agarwal
AU  - Avijit Kumar Bakshi
AU  - Dilip Panwar
AU  - Patil Rohit Santosh
AU  - Prabhat Ranjan Mishra
PY  - 2026
JO  - Drug Development and Industrial Pharmacy
DO  - 10.1080/03639045.2026.2703044
UR  - https://doi.org/10.1080/03639045.2026.2703044
ER  - 

APA

Agarwal, N., Bakshi, A. K., Panwar, D., Santosh, P. R., & Mishra, P. R. (2026). Rutin-enabled improved systemic exposure of doxorubicin via nanostructured lipid carriers: a proof of concept through novel LC-MS/MS analysis. Drug Development and Industrial Pharmacy. https://doi.org/10.1080/03639045.2026.2703044

Source records